Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 718 | 132 | 6,272 | 130 | 76 |
| Gross Profit | 718 | 132 | 6,272 | 130 | 76 |
| Operating Expenses | 13,011 | 12,655 | 11,345 | 12,680 | 10,801 |
| Operating Income | -12,293 | -12,523 | -5,073 | -12,550 | -10,725 |
| Other Income | 21,956 | 365 | 389 | 2,315 | 1,471 |
| Pre-tax Income | 9,663 | -12,158 | -4,684 | -10,235 | -9,254 |
| Net Income Continuous | 9,663 | -12,158 | -4,684 | -10,235 | -9,254 |
| Net Income | $9,663 | $-12,158 | $-4,684 | $-10,235 | $-9,254 |
| EPS Basic Total Ops | 0.14 | -0.17 | -0.06 | -0.14 | -0.12 |
| EPS Basic Continuous Ops | 0.14 | -0.17 | -0.07 | -0.14 | -0.13 |
| EPS Diluted Total Ops | 0.14 | -0.17 | -0.06 | -0.14 | -0.12 |
| EPS Diluted Continuous Ops | 0.14 | -0.17 | -0.07 | -0.14 | -0.13 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -0.17 | -0.06 | -0.14 | -0.13 |
| EBITDA(a) | $-12,276 | $-12,507 | $-4,974 | $-12,409 | $-10,565 |